82 related articles for article (PubMed ID: 1791799)
1. [Surfactant and ambroxol in the therapy of idiopathic respiratory syndrome in newborn infants].
Carrera G; Liberatore A; Riboni G; Clementi M
Minerva Pediatr; 1991 Nov; 43(11):723-30. PubMed ID: 1791799
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of intravenous or atomizing ambroxol for prevention of respiratory distress syndrome in preterm infants].
Hu Q; Lian JM; Li JQ
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):301-3. PubMed ID: 16923362
[TBL] [Abstract][Full Text] [Related]
3. [Ambroxol in the treatment of idiopathic respiratory distress syndrome].
Durisová A
Cesk Pediatr; 1992 Jul; 47(7):421-3. PubMed ID: 1394543
[TBL] [Abstract][Full Text] [Related]
4. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
[TBL] [Abstract][Full Text] [Related]
5. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
Dunn MS; Shennan AT; Zayack D; Possmayer F
Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
[TBL] [Abstract][Full Text] [Related]
6. [Effects of surfactant administration in premature infants with severe respiratory distress syndrome].
Morón A; Luaces J; Esteban JC; Medina D; Sánchez JM; Manzano JL
Med Clin (Barc); 1996 Jun; 107(5):165-8. PubMed ID: 8758674
[TBL] [Abstract][Full Text] [Related]
7. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial.
Escobedo MB; Gunkel JH; Kennedy KA; Shattuck KE; Sánchez PJ; Seidner S; Hensley G; Cochran CK; Moya F; Morris B; Denson S; Stribley R; Naqvi M; Lasky RE;
J Pediatr; 2004 Jun; 144(6):804-8. PubMed ID: 15192630
[TBL] [Abstract][Full Text] [Related]
8. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
9. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology of ambroxol--review and new results.
Disse BG
Eur J Respir Dis Suppl; 1987; 153():255-62. PubMed ID: 3322865
[TBL] [Abstract][Full Text] [Related]
11. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation.
Plavka R; Kopecký P; Sebron V; Leiská A; Svihovec P; Ruffer J; Dokoupilová M; Zlatohlávková B; Janus V; Keszler M
Intensive Care Med; 2002 Oct; 28(10):1483-90. PubMed ID: 12373475
[TBL] [Abstract][Full Text] [Related]
12. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
13. [Administration of exogenous surfactant in premature very low birth weight infants with RDS].
Iarŭkova N; Vakrilova L; Slŭncheva B; Dancheva S; Popivanova A; Emilova Z; Dimitrov A; Chernev T; Nikolov A
Akush Ginekol (Sofiia); 1999; 38(1):23-6. PubMed ID: 11965714
[TBL] [Abstract][Full Text] [Related]
14. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
Teksam O; Kale G
Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732
[TBL] [Abstract][Full Text] [Related]
15. Surfactant therapy in respiratory distress syndrome--the first local experience.
Lim NL; Nordin MM; Cheah IG
Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
[TBL] [Abstract][Full Text] [Related]
16. Ambroxol in the treatment of idiopathic respiratory distress syndrome. An interim report on a controlled double-blind multicenter study versus placebo.
Marini A; Franzetti M; Gios G; Flauto U; Arosio A; Maccabruni M; Rondini G; Chirico G; Giancola A; Console V
Respiration; 1987; 51 Suppl 1():60-7. PubMed ID: 3299568
[TBL] [Abstract][Full Text] [Related]
17. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
[TBL] [Abstract][Full Text] [Related]
18. Open lung ventilation preserves the response to delayed surfactant treatment in surfactant-deficient newborn piglets.
van Veenendaal MB; van Kaam AH; Haitsma JJ; Lutter R; Lachmann B
Crit Care Med; 2006 Nov; 34(11):2827-34. PubMed ID: 17006360
[TBL] [Abstract][Full Text] [Related]
19. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
[TBL] [Abstract][Full Text] [Related]
20. [Antenatal ambroxol administration for prevention of respiratopry distress syndrome in preterm infants: preliminary report].
Marinov B; Jekova N; Andreeva A; Hitrova S
Akush Ginekol (Sofiia); 2011; 50(4):17-22. PubMed ID: 22479892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
